A Day Up For Lumos Pharma, Inc.
Fri, Aug 16, 2024 at 07:22 PM
Lumos Pharma, Inc. (LUMO:NASDAQ) shot up at $3.27, representing a gain of 33.5%. On Fri, Aug 16, 2024, LUMO:NASDAQ touched a New 2-Week High of $3.27. The stock got featured on our News Catalysts scanner on Fri, Aug 16, 2024 at 04:14 AM in the 'ACQUISITION' category. From Fri, Aug 02, 2024, the stock recorded 70.00% Up Days and 63.64% Green Days
About Lumos Pharma, Inc. (LUMO:NASDAQ)
Lumos Pharma Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, is in late-stage clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD).
Top 10 Gainers:
- Cingulate Inc. (CING:NASDAQ), 268.54%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 78.22%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 60.27%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 59.52%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 53.24%
- Inspirato Inc Cl A (ISPO:NASDAQ), 40.69%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 40.63%
- Vroom Inc. (VRM:NASDAQ), 34.83%
- Lumos Pharma, Inc. (LUMO:NASDAQ), 33.47%
- Yoshiharu Global Co. (YOSH:NASDAQ), 32.77%